An observational study in Blood Pressure and Hypotension Drug-Induced, sponsored by Heidelberg University. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-10-26.
Sponsored by Heidelberg University · Observational
The induction of anaesthesia is one of the most critical situations for high-risk-patients undergoing interventions surgery. For several reasons, it is crucial to maintain adequate blood pressure and cardiac output during this phase.
This retrospective cohort study aims to find out if the choice of the induction agent has a major impact on blood pressure and the use of catecholamines during the induction and the interventional procedure in patients undergoing interventional mitral valve repair.
1,003 studies on the registry are indexed under Hypotension; 173 are open to participants now.
This study's enrollment of 57 is below the median of 84 across 294 observational studies indexed under Hypotension.
Browse Hypotension studies →Heidelberg University is the lead sponsor of 279 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients undergoing interventional mitral valve repair
Exclusion Criteria:
Patients who received etomidate for induction of anaesthesia during interventional mitral valve repair (Mitraclip)
Drug: Etomidate
Patients who received sevoflurane for induction of anaesthesia during interventional mitral valve repair (Mitraclip)
Drug: Sevoflurane
Use of etomidate
Use of sevoflurane
Post-induction hypotension
Hypotension in the first 20 minutes after induction of anesthesia
Time frame: First 20 minutes after induction of anaesthesia
Use of catecholamines after induction during the first 20 minutes after inductionafter induction
Use of catecholamines during the first 20 minutes after induction of anaesthesia
Time frame: First 20 minutes after induction
Use of catecholamines
Use of catecholamines during the procedure
Time frame: Length of procedure (Approximately 60 to 90 minutes in average)
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Heidelberg University